TABLE 2.
First author, year [ref.] | Length of treatment | Macrophages | Neutrophils | Eosinophils | Mast cells | Lymphocytes |
Confalonieri, 1998 [ 74 ] | 2 months (ICS) | ↑ | ↓ | = | X | = |
Culpitt, 1999 [ 72 ] | 1 month (ICS) | = | = | = | X | = |
Yildiz, 2000 [ 73 ] | 2 months (ICS) | = | ↓ | = | X | = |
Loppow, 2001 [ 71 ] | 1 month (ICS) | = | = | = | X | = |
Mirici, 2001 [ 97 ] | 3 months (ICS) | ↑ | = | = | X | = |
Sugiura, 2003 [ 67 ] | 1 month (ICS) | = | = | ↓ | X | = |
Brightling, 2005 [ 70 ] | 6 weeks (ICS) | = | = | = | X | = |
Barnes, 2006 [ 63 ] | 3 months (ICS/LABA) | X | ↓ | ↓ | X | X |
Reid, 2008 [ 59 ] | 6 months (ICS) | = | = | = | = | = |
Lapperre, 2009 [ 60 ] | 6 months (ICS) | = | = | = | X | = |
6 months (ICS/LABA) | = | = | = | X | = | |
30 months (ICS) | ↓ | ↓ | = | X | ↓ | |
30 months (ICS/LABA) | ↓ | ↓ | = | X | ↓ | |
Boorsma, 2008 [ 69 ] | 6 months (ICS) | = | = | = | X | = |
Asai, 2015 [ 68 ] | 3 months (ICS/LABA) | X | = | X | X | X |
=: no change; ↑: increase; ↓: decrease; X: not measured. LABA: long-acting β-agonist.